Score Overview
Explore the 2021 public Archive ranking →
Where Cognition Therapeutics Inc has ranked, year by year
Not enough ranking history to display a chart
This chart needs at least two years of available HDB Score rankings on 10 years of fundamentals. CGTX does not have enough ranked years in the public Archive through 2021.
More recent Archive years are available with Membership. Coverage varies by company and measure.
Net Income x Stock Price
Historical Returns
| Period | Price | Return |
|---|---|---|
Last Price2026-10-02 | $ 0.93 | — |
1 Year2025-10-02 | $ 1.43 | -35.31% |
All Time2021-10-08 | $ 12.77 | -92.76% |
| Period | Last Price2026-10-02 | 1 Year2025-10-02 | All Time2021-10-08 |
|---|---|---|---|
| Price | $ 0.93 | $ 1.43 | $ 12.77 |
| Return | — | -35.31% | -92.76% |
Prices are split & dividend adjusted. All values are reported in USD.
Fundamental Data
Reported in USD
| Year | |||
|---|---|---|---|
| TTM | $ 0.00 | -$ 16M | $ 34M |
| 2025 | $ 0.00 | -$ 23M | $ 36M |
| 2024 | $ 0.00 | -$ 33M | $ 25M |
| 2023 | $ 0.00 | -$ 25M | $ 29M |
| 2022 | $ 0.00 | $ 757K | $ 41M |
| IPO2021 | $ 0.00 | -$ 11M | $ 54M |
Cognition Therapeutics Inc fundamental performance
Across Cognition Therapeutics Inc's full reported history, from 2021 to 2025, revenue held from $ 0.00 to $ 0.00 and net income went from -$ 11M to -$ 23M. Revenue increased in 0% of the years measured; net income in 60%.
Membership
Explore CGTX with current data
The public Archive runs through 2021. Membership adds recent and current rankings.
- Recent and current rankings across 3,813 companies
- Compare companies with the latest data
- Track your research shortlist in a portfolio
